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Abstract 
 
Obstructive sleep apnea (OSA) is a disorder characterized by airflow 
interruptions during sleep, and has been linked to increased incidence of stroke. 
Intermittent hypoxia (IH) in experimental animals can partially recapitulate the 
physiology of OSA. Previous studies have indicated that IH stimulates protective 
mechanisms in the brain that can protect against stroke. This protection is termed, 
preconditioning; the temporal requirements of IH treatment that produce 
preconditioning are not known. To explore the potential role of short-term versus 
chronic IH in stroke outcome, we analyzed infarct volume and expression of 
proinflammatory cytokine gene expression (TNF-α, IL-6 and IL-1β) after stroke in 
mice treated with IH or room air for 11 or 20 days.   
Mice experiencing IH for 11 days prior to stroke and 1 day after reperfusion 
decreased gene expression of both IL-6 and IL-1β. When assessed 3 days post-stroke 
infarct volume was decreased in mice that received IH prior to stroke and room air 
after stroke compared to mice treated with air prior to and after stroke. These 
results were not observed in mice that experienced IH 20 days prior to stroke and 3 
days after stroke. These results suggest that short-term IH prior to stroke is 
protective and reduces both infarct volume and inflammatory gene expression 
compared to long-term IH prior to stroke.    
 
 
 
Introduction 
 
Obstructive sleep apnea (OSA) is a condition in which airflow is repetitively 
decreased or stopped while sleeping. OSA is highly prevalent in the population and 
leads to significant morbidity, even in mild cases1. Specifically, OSA is known to be 
associated with increased likelihood of stroke1. Stroke is the third-leading cause of 
death and the leading cause of long-term disability in the Western world2. During 
ischemic stroke the brain is deprived of oxygenated blood and nutrients leading to 
necrosis of neural tissue. The resulting damage to neuronal tissue can be 
devastating and produce lasting sensorimotor deficits. Although it is unclear 
whether OSA is an independent risk factor for stroke or whether it takes effect only 
in the presence of other traditional cardiovascular risk factors, there is certainly an 
association between the two that should be investigated3. The current predominant 
treatment for stroke is thrombolysis, but many individuals with a high risk for 
stroke might instead benefit from therapies that improve the brain’s resistance to 
ischemic injury prior to stroke onset4. 
Ischemic stroke results in necrosis of tissue, or infarcted tissue, in the 
immediate area in which the insult occurred. This damage incurred after stroke is 
two-fold. Initially there is damage from apoptotic cell death resulting from oxygen 
deprivation during the acute focal ischemia5. That damage reflects how long and to 
what extent the vessel in the brain was occluded. Secondary damage is caused by 
inflammatory processes incited by microglia present in the central nervous system 
that takes several days to develop after the initial injury6. This presents a 
therapeutic window during which interventions may improve the outcome for 
patients. One way to quantify damage after stroke is infarct volume, which measures 
the amount of necrotic tissue post-stroke. Another way to evaluate the brain post-
stroke is by measuring the presence of certain inflammatory cytokines. Microglia 
release and respond to many inflammatory cytokines such as interleukin-6 (IL-6), 
interleukin 1-beta (IL-1β), and proinflammatory tumor necrosis factor alpha (TNF-
α)7. Following stroke the expression of these cytokines are up-regulated, facilitating 
inflammatory cascades which cause further cerebral infarction5. Although some 
neuroinflammation is key to recovery, failure to regulate these processes can lead to 
additional damage in the days following stroke8. 
Intermittent hypoxia (IH), or repetitive cycling between hypoxia and 
reoxygenation, can be utilized as a model for OSA in mice because animals 
undergoing IH treatment exhibit blood oxygen levels consistent with OSA patients9. 
Animal models of IH have also shown changes in blood pressure consistent with 
those observed in OSA patients10. OSA has been associated with increased mortality 
following stroke11. Therefore, it is plausible to suggest that IH may universally cause 
an increase in inflammatory cytokines IL-6, IL-1β, and TNF-α leading to more severe 
damage after stroke. However, this may depend on the duration of IH exposure 
because IH is observed to have differing effects depending on exposure length. 
Exposure to IH lasting up to 14 days is generally considered acute while anything 
longer is considered chronic. Exposure to acute IH appears to stimulate 
neurogenesis and reduces depressive-like behavior12,13, but is also associated with 
increased TNF-α gene expression14. However, chronic IH is associated with impaired 
cognitive function, increased inflammation and oxidative stress9. In a study utilizing 
IH as a model for OSA, increased levels of pro-inflammatory cytokines were present 
in animals receiving IH treatment15. Expression of IL-6 and IL-1β are known to 
increase after arterial occlusion and facilitates the inflammatory process by 
mediating inflammatory cascades5. Therefore a mechanism that decreases 
expression of these inflammatory cytokines would also decrease damage after 
stroke. Preclinical models have demonstrated that exposure to hypoxia is generally 
protective for only a few days, however a repetitive hypoxic environment can 
extend the preconditioning effect of hypoxia in stroke for up to 2 months after 
completion of IH treatment4. However, it is still unknown how longer durations of 
IH will affect stroke outcome. 
 
Problem Identification and Justification  
 
Previous literature has demonstrated patients with OSA are at an increased 
risk for stroke16. It is therefore important and relevant to investigate the disparity 
between the apparent preconditioning role for IH in stroke and the known 
relationship between OSA and increased incidence of stroke. A potential explanation 
could be the length of exposure to IH, because most patients with OSA do not 
experience the effects of IH over a short period of time. As mentioned, IH has 
differing effects depending on duration of exposure. Since studies that observed a 
preconditioning effect for IH in stroke involved administering treatment for a brief 
duration, this research investigated the effects of IH for longer time each day and 
over many days. The study aimed to determine whether short-term IH (11+3) or 
chronic IH (20+3 days) experienced for 8 h/day also has a preconditioning role.  
 
Hypothesis 
 
I hypothesize that infarct volume will increase proportionally across the 
treatment groups (Table 1). Infarct volume should be smallest in the air/air 
treatment groups and largest in the IH/IH treatment groups. I also hypothesize that 
this will be mirrored by decreased expression of inflammatory markers (IL-6, IL-1β, 
TNF-α) in the stroke hemisphere. I expect the results to indicate that IH does not 
have a preconditioning role against stroke when exposure occurs for a longer 
duration (20 days). 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods  
 
Figure 1. Diagram of short vs. long-term groups. Mice received either 11 (short-
term) or 20 (long-term) days of air or IH treatment, were subjected to a stroke, and 
were then placed back into treatment (IH or air) for 1 or 3 days. 
 
 
Figure 2. Oxygen levels fluctuated in the IH chamber between 21% and 5%. 
 
 
 Pre-stroke 
Treatment  
Post-stroke 
Treatment 
Group  1 Air Air 
Group  2 IH Air 
Group  3*  Air IH 
Group  4 IH IH 
Table 1. Treatment groups; two sets of animals for infarct volume short-term (11+1 
days and 11+3 days), one set for infarct volume long-term (20+3 days), and a third 
set for gene expression short-term (11+1 days). *Group 3 was omitted in the short-
term study (11+3 days). 
Animals 
Adult male C57/Bl6 (> 8 weeks, ~ 23g) mice were acclimated to the facility 
for one week. Mice were group housed in a 14:10 light/dark cycle on ventilated 
racks in a temperature- and humidity- controlled vivarium with ad libitum access to 
food (Harlan 8640 Teklad Rodent Diet) and filtered tap water.  
 
Intermittent Hypoxia 
Mice were then exposed to either 11 or 20 days of room air or IH (15 
cycles/hr, 8hr/day, FIO2 nadir of 5%) (Figure 1). Eleven days of pre-stroke 
treatment refers to the short-term model, and 20 days of pre-stroke treatment 
refers to the long-term model. During this treatment mice were moved to custom-
designed Plexiglas chambers (31 cm x 19 cm x 18 cm) with a raised floor (6.5 cm) 
during the light cycle and moved into home cages in a separate room during the 
dark cycle. Twelve mice were placed in one chamber at a time. Oxygen levels were 
controlled by connecting the cages via a regulator system to compressed air and 
nitrogen tanks. The oxygen levels (21%- 5%) cycled throughout the day (Figure 2). 
Fluctuation in chamber oxygen levels was achieved by alternating 3 min of 
breathing air and 1 min of nitrogen. Mice exposed to room air were housed in a 
similar cage, without connections to nitrogen or air tanks. Treatment occurred 
during the light phase (when these animals typically sleep) to mimic when OSA 
would occur in patients. 
 
 
Middle Cerebral Artery Occlusion 
On the twelfth or twenty-first day mice were subjected to a middle cerebral 
artery occlusion (MCAO), which causes transient focal cerebral ischemia17. Briefly, 
mice were anesthetized with isoflurane in oxygen, and unilateral right MCAO was 
achieved by insertion of a 6-0 nylon monofilament into the internal carotid artery to 
a point 6 mm beyond the internal carotid-pterygopalatine artery bifurcation. After 
the monofilament was secured, the wound was sutured. Occlusion occurred for 60 
min, during which mice were allowed to recover from anesthesia. After 60 min the 
animal was re-anesthetized and reperfusion was initiated by removal of the 
filament. Animals were then allowed to recover until treatment the next morning. 
The following day animals were placed back in either air or IH treatment for 1 or 3 
days. See Figure 1 for a flowchart depicting the different treatments.  
 
Tissue Collection and Processing 
After the conclusion of treatment animals were anesthetized with isoflurane 
vapors and euthanized via rapid cervical dislocation and decapitation. Brains were 
rapidly removed, frozen on dry ice for 5 min, and then sectioned into five 2-mm-
thick coronal sections. Sections were processed with 2,3,5- triphenyltetrazolium 
chloride (TTC) and incubated for 12 min in a water bath held at 37° C. TTC is 
processed by living mitochondria and turns the living tissue red while dead tissue 
remains white, allowing comparison of infarct volume across groups. Following 
staining sections were fixed in formalin for at least 24 h. Then brain slices were 
photographed and analyzed using Inquiry software (Loats Associates, Inc., 
Westminster, MD). Infarct size was calculated as a percentage of the contralateral 
hemisphere after correcting for edema using the following formula: [(1-(total 
ipsilateral hemisphere-infarct))/total contralateral hemisphere] *100. 
One cohort of mice receiving the 11 day pre- stroke/1 day post-stroke 
treatment was used for gene expression. Mice were euthanized during the light 
phase, and brains were collected and placed in RNAlater (Applied Biosystems, 
Foster City, CA). After > 24 hr the cortex was dissected out for PCR. The RNA was 
extracted using a handheld homogenizer (Fisher Scientific, Waltham, MA) and 
TRIzol Reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s 
Transcriptase enzyme (Invitrogen, Carlsbad, CA) according to the manufacturer’s 
guidelines. Proinflammatory cytokine expression of IL-1β, IL-6, and TNF-  were 
determined using primer and probe assays kits (Applied Biosystems, Foster City, 
CA) on an ABI 7500 Fast Real Time PCR System using Taqman Universal PCR Master 
Mix. The universal two-step RT-PCR cycling conditions used were: 50° C for 2 min, 
95° C for 10 min, followed by 40 cycles of 95° C for 15 s and 60° C for 1 min. Relative 
gene expression of samples run in duplicate were calculated based on a relative 
standard curve and standardized to 18s rRNA signal. 
 
 
 
 
 
Statistical Analysis 
Infarct volumes were compared using T-tests to assess planned comparisons 
between groups. Cytokine expression was analyzed with Kruskal-Wallis test due to 
unequal variances among groups, and followed up by Mann-Whitney U post hoc 
tests assessing effects of pre and post MCAO treatment (room air or IH) and 
hemisphere (ipsilateral and contralateral). Differences were considered significant 
at p<0.05, and were followed up with post-hoc tests. Statistics were conducted using 
SPSS 19 for Windows (IBM, Armonk, New York, USA).  
 
Results 
 
Infarct Volume 
When analyzed 1 day after MCAO in the 11-day pre-stroke model, no 
differences were observed in percent infarct between treatment groups (p>0.05). 
When analyzed 3 days after MCAO in the 11-day pre-stroke model, mice that 
received IH prior to and air following MCAO (M=15.89, SD=13.64) had reduced 
percent infarct compared to mice exposed to only room air (M=32.80, SD=17.04); 
t(14)=2.21, p=0.044). In the same model, mice exposed to only IH (M=25.15, 
SD=13.71) displayed similar percent infarct compared to mice exposed to IH only 
prior to MCAO (M=15.89, SD=13.64) and mice exposed only to room air (M=32.80, 
SD=17.04, p>0.05).  When analyzed 3 days after MCAO in the 20-day pre-stroke 
model, no differences were observed in percent infarct among groups (p>0.05). (See 
Figure 3A-3C) 
 
3A. 12 Day Exposure (11 Days Pre Stroke, 1 Day Post Stroke) 
 
3B. 14 Day Exposure (11 Days Pre Stroke, 3 Days Post Stroke) 
 
3C. 23 Day Exposure (20 Days Pre Stroke, 3 Days Post Stroke) 
 
Figure 3. Infarct volume was reduced in mice experiencing IH prior to stroke. 
Percent of hemisphere damaged one day following middle cerebral artery occlusion 
(MCAO) was similar among groups exposed to 11 days of treatment prior to MCAO 
(A). Percent of hemisphere damaged three days following MCAO was reduced in 
mice exposed to 11 days of IH prior to MCAO (B). Percent of hemisphere damaged 
three days following MCAO was similar among groups exposed to 20 days of 
treatment prior to MCAO (C). *indicates significant differences at p<0.05. 
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Inflammatory Gene Expression 
Tissue was collected for inflammatory gene expression in the short-term 
11+1 day model. Following one day of treatment after MCAO IL-6 gene expression 
was increased in the ipsilateral hemisphere compared the contralateral hemisphere 
(U(1)=12, Z= -4.25, p<0.05). IL-6 was increased in the ipsilateral hemisphere of 
air/air treated mice compared to IH/air treated mice (U(1)=1, Z= -2.21, p<0.05). IL-
1β gene expression was increased in the ipsilateral hemisphere compared to the 
contralateral hemisphere (U(1)=58, Z= -2.63, p<0.05). IL-1β was increased in the 
ipsilateral hemisphere of air/air treated mice compared to IH/IH treated mice 
(U(1)=0, -2.88, p<0.05). IL-1β was increased in the ipsilateral hemisphere of air/air 
treated mice compared to IH/IH treated mice (U(1)=0, -2.88, p<0.05). TNF-α gene 
expression was increased in both hemispheres in mice exposed to air throughout 
the entire experiment compared to mice exposed only to IH (U(1)=0, Z=-
2.88, p<0.05). Mice exposed to IH prior to stroke and air after stroke increased TNF-
α gene expression only in the ipsilateral hemisphere (U(1)=1, Z=-2.40, p<0.05). TNF-
α gene expression was similar in both hemispheres in mice exposed only to IH 
(p>0.05). (See Figure 4A-4C) 
 
 
4A. Gene expression of IL-6 
 
4B. Gene expression of IL-1β 
 
4C. Gene expression of TNF-α 
Figure 4. Inflammatory gene expression was reduced in mice experiencing IH 
prior to stroke.  Relative gene expression of IL-6  (A) and IL-1β (B) was decreased 
one day following MCAO in mice exposed to IH compared to mice exposed only to 
air. Relative gene expression of TNF-α (C) was decreased one day following MCAO in 
mice exposed to IH prior to stroke and air after stroke only in the ipsilateral 
hemisphere. * indicates significant differences within a hemisphere, # indicates 
significant differences from all other groups in contralateral hemisphere, & indicates 
significant differences in the same group between the ipsilateral and contralateral 
hemispheres at p< 0.05. 
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Discussion 
 
OSA is associated with increased risk for stroke, and can be modeled by 
intermittent hypoxia (IH) treatment in mice1,9. Previous literature indicates a 
preconditioning role for short-term IH in stroke, but the effect of long-term IH is still 
undetermined4. Therefore we subjected mice to both short- (11 days) and long- (20 
days) term IH treatment and observed the effect each of these treatments had on 
stroke outcome assessed by infarct volume and inflammatory gene expression of IL-
6, IL-1β and TNF-α. The results indicated a preconditioning effect of short-term IH 
when analyzed 1 day after stroke because infarct volume and inflammatory gene 
expression were both significantly decreased compared to other groups. This 
preconditioning effect was absent in the long-term IH model.  
The differences observed between analyzing infarct 1 or 3 days after stroke 
suggest that a mechanism of penumbral sparing is at work. In ischemic stroke, there 
are two areas of injury – the core, and the penumbra. The core represents the 
damage from the initial insult, and constitutes dead tissue that cannot be saved. The 
penumbra, while at risk for becoming infarct, still has the potential to be saved. The 
penumbra represents the area surrounding the core injury and is the area of focus 
when trying to improve stroke outcome18. Infarct volume in mice takes 3 days to 
fully develop as the penumbra is saved or the core expands19. Therefore, observing 
differences 3 days after stroke but not 1 day after stroke indicates that after 1 day 
only the core injury is being measured, and that the penumbral tissue is still alive 
though at risk. After 3 days, the observed decline in infarct volume in animals 
treated with IH indicates IH played a role in sparing the penumbra in those animals. 
Additionally, the data indicate that this protective effect is not present when 
exposed to a long-term duration of IH. 
The results for IL-6 and IL-1β also suggest a mechanism of penumbral 
sparing because inflammation, while beneficial in many cases, can cause further 
damage after stroke if it is too excessive8. Therefore, observing decreased 
expression of IL-6 and IL-1β only in animals that received IH treatment indicates IH 
plays a role in limiting inflammation after a stroke. The observed increase in TNF-α 
may also be linked to protective effects because it is only seen in the hemisphere 
that received the stroke. This indicates the inflammatory response is more localized 
and is lessened. Whereas mice exposed to air throughout the experiment had 
increases in TNF-α gene expression in both hemispheres, suggesting dysregulated 
control of the inflammatory response. Gene expression was analyzed 1 day after 
stroke in the 11-day exposure model. Observing decreases in IL-6 and IL-1β 
expression at 1 day after stroke but not observing changes in infarct volume at this 
point indicates that the decreased inflammatory response at 1 day after stroke sets 
up an environment in which there will be controlled inflammation to allow more 
tissue sparing at three days following stroke.   
 
 
 
 
 
Conclusion 
 
Short-term exposure to intermittent hypoxia has a preconditioning effect on 
stroke in mice. Decreased expression of inflammatory genes IL-6 and IL-1β along 
with the observation of decreased infarct volume when assessed 3, but not 1 day 
post stroke together suggest a mechanism of penumbral sparing by decreased 
inflammation in the brain. Intermittent hypoxia before stroke sets up an 
environment in which there will be controlled inflammation to allow sparing of the 
penumbra. However, long-term exposure to IH does not protect against stroke 
damage. These results have potential implications for deriving clinical therapies of 
short-term IH exposure in individuals at high risk for stroke.  
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